Literature DB >> 6871891

Thymidine and 5-FU: a Phase II pilot study in colorectal and breast carcinomas.

C A Presant, P Multhauf, L Klein, C Chan, F F Chang, G Hum, R Joseph, R Opfell, S Lemkin, T Shiftan, D Plotkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6871891

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

1.  Likelihood-based estimation of microsatellite mutation rates.

Authors:  John C Whittaker; Roger M Harbord; Nicola Boxall; Ian Mackay; Gary Dawson; Richard M Sibly
Journal:  Genetics       Date:  2003-06       Impact factor: 4.562

2.  Schedule-dependent antitumor and toxic effects of thymidine and 5-fluorouracil in AKR and L1210 leukemias.

Authors:  G Santelli; F Valeriote
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.